UnitedHealth Group Incorporated $UNH Shares Purchased by Live Oak Private Wealth LLC

Live Oak Private Wealth LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 38.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 35,062 shares of the healthcare conglomerate’s stock after buying an additional 9,756 shares during the quarter. UnitedHealth Group accounts for 1.6% of Live Oak Private Wealth LLC’s investment portfolio, making the stock its 17th largest position. Live Oak Private Wealth LLC’s holdings in UnitedHealth Group were worth $10,938,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. Caitlin John LLC increased its position in shares of UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares in the last quarter. Triumph Capital Management acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $1,324,000. Wealth Effects LLC lifted its stake in shares of UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares during the last quarter. Arlington Partners LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $2,229,000. Finally, Folger Nolan Fleming Douglas Capital Management Inc. lifted its stake in shares of UnitedHealth Group by 14.6% in the 2nd quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 28,798 shares of the healthcare conglomerate’s stock valued at $8,984,000 after purchasing an additional 3,660 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on UNH shares. Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Bank of America upped their price target on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. UBS Group increased their target price on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday. KeyCorp increased their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Finally, Sanford C. Bernstein increased their target price on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $395.64.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $356.05 on Thursday. The stock’s 50-day moving average is $342.00 and its two-hundred day moving average is $331.00. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a market cap of $322.47 billion, a price-to-earnings ratio of 18.58, a price-to-earnings-growth ratio of 2.37 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter in the prior year, the business earned $7.15 EPS. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.